443 institutions hold shares in Medpace Holdings Inc. (MEDP), with 7.56M shares held by insiders accounting for 21.03% while institutional investors hold 100.94% of the company’s shares. The shares outstanding are 35.58M, and float is at 28.52M with Short Float at 2.72%. Institutions hold 79.71% of the Float.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The top institutional shareholder in the company is Blackrock Inc. with over 3.79 million shares valued at $527.73 million. The investor’s holdings represent 10.53% of the MEDP Shares outstanding. As of Dec 30, 2020, the second largest holder is Vanguard Group, Inc. (The) with 3.34 million shares valued at $464.54 million to account for 9.27% of the shares outstanding. The other top investors are Wasatch Advisors Inc which holds 2.84 million shares representing 7.89% and valued at over $395.47 million, while State Street Corporation holds 2.39% of the shares totaling 0.86 million with a market value of $120.0 million.
Medpace Holdings Inc. (NASDAQ: MEDP) is 21.62% higher on its value in year-to-date trading and has touched a low of $73.62 and a high of $196.12 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MEDP stock was last observed hovering at around $167.82 in the last trading session, with the day’s gains setting it 1.47% off its average median price target of $180.50 for the next 12 months. It is also 15.36% off the consensus price target high of $200.00 offered by 6 analysts, but current levels are -5.81% lower than the price target low of $160.00 for the same period.
Currently trading at $169.29, the stock is -4.41% and 1.09% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.25 million and changing 0.88% at the moment leaves the stock 23.56% off its SMA200. MEDP registered 100.75% gain for a year compared to 6-month gain of 54.77%. The firm has a 50-day simple moving average (SMA 50) of $170.92 and a 200-day simple moving average (SMA200) of $145.60.
The stock witnessed a 4.20% loss in the last 1 month and extending the period to 3 months gives it a 26.39%, and is -9.71% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.95% over the week and 3.47% over the month.
Medpace Holdings Inc. (MEDP) has around 3600 employees, a market worth around $5.97B and $925.90M in sales. Current P/E ratio is 44.07 and Fwd P/E is 32.39. Profit margin for the company is 15.70%. Distance from 52-week low is 129.95% and -13.68% from its 52-week high. The company has generated returns on investments over the last 12 months (17.90%).
Medpace Holdings Inc. (MEDP) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Medpace Holdings Inc. (MEDP) is a “Overweight”. 6 analysts offering their recommendations for the stock have an average rating of 2.30, where 3 rate it as a Hold and 0 think it is a “Overweight”. 3 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Medpace Holdings Inc. is expected to release its quarterly report on 08/02/2021 and quarterly earnings per share for the current quarter are estimated at $1.04 with sales reaching $275.03M over the same period.The EPS is expected to grow by 44.20% this year, but quarterly earnings will post 23.00% year-over-year. Quarterly sales are estimated to grow 34.20% in year-over-year returns.
Medpace Holdings Inc. (MEDP) Insider Activity
A total of 66 insider transactions have happened at Medpace Holdings Inc. (MEDP) in the last six months, with sales accounting for 46 and purchases happening 20 times. The most recent transaction is an insider sale by Troendle August J., the company’s President & CEO. SEC filings show that Troendle August J. sold 20,729 shares of the company’s common stock on Apr 26 at a price of $193.38 per share for a total of $4.01 million. Following the sale, the insider now owns 6.32 million shares.
Medpace Holdings Inc. disclosed in a document filed with the SEC on Apr 26 that Medpace Investors, LLC (10% Owner) sold a total of 20,729 shares of the company’s common stock. The trade occurred on Apr 26 and was made at $193.38 per share for $4.01 million. Following the transaction, the insider now directly holds 6.32 million shares of the MEDP stock.
Still, SEC filings show that on Apr 23, Troendle August J. (President & CEO) disposed off 7,805 shares at an average price of $190.51 for $1.49 million. The insider now directly holds 6,340,721 shares of Medpace Holdings Inc. (MEDP).